Dexamethasone Inhibits Retinal Neovascularization and VEGF Expression

LIU Wen-hui,LI Yi-zhuang,WU Yong-qing
DOI: https://doi.org/10.3969/j.issn.1008-8199.2008.04.010
2008-01-01
Abstract:Objective: To explore the therapeutic effect of dexamethasone on proliferative retinopathy in different stages and its interaction with the vascular endothelial growth factor(VEGF).Methods: Models of oxygen-induced retinopathy(OIR) were established.Twenty C57BL/6J mice pups(7 days after birth) were randomized into 4 groups: normal control,pure OIR,early-treatment and late-treatment.Dexamethasone was administered at the dose of 0.5 mg/kg·d-1by subcutaneous injection to the early-treatment group from postnatal day 7 and to the late-treatment group from day 12,both for 5 days.Common pathological sections were made from both eyeballs of the C57BL/6J mice and detected by immunohistochemistry to count the nuclei of proliferative retinal vessel cells and investigate the expression of VEGF in the retina.Results: The nuclei of proliferative retinal vessel cells and the expressions of VEGF significantly increased in the pure OIR group as compared with the normal control(P0.01),but markedly decreased in the early-and late-treatment groups compared with the pure OIR group(P0.01) as well as in the early-treatment group in comparison with the late-treatment group(P0.01).Conclusion: Dexamethasone significantly inhibits retinal neovascularization and VEGF expression in the mouse model of oxygen-induced retinopathy,with obviously better therapeutic effect in the early stage than in the late stage.
What problem does this paper attempt to address?